Medable’s CSO opens up on rethinking clinical drug development

Direct-to-patient clinical trial company Medable (Palo Alto, California) has recently hired MaryAnne Rizk as its chief strategy officer. Rizk was IQVIA’s former senior vice president, digital R&D strategy. 

Rizk was also recently named a PharmaVoice 100 leader.

Rizk is also a graduate advisor and an adjunct professor for the school of engineering at the Stevens Institute of Technology (Hoboken, New Jersey), where she founded the Pharmaceutical Alumni Association and earned a doctorate in technology management, systems engineering.

In the following Q&A, Rizk touches on what inspired her to join Medable, her core goals and what inspires her.  

Drug Discovery & Development: What inspired you to join Medable?

Rizk: I came home. Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies, which aligns with my mission. Medable’s culture truly aligns with …

Read more
  • 0

Medable installs new chief strategy officer 

Direct-to-patient clinical trial company Medable (Palo Alto, California) has added MaryAnne Rizk to its executive team.

Rizk formerly worked at IQVIA as a senior vice president, digital R&D strategy. She is also an adjunct professor at the Steven Institute of Technology (Hoboken, New Jersey) and a managing partner at Rizk Management Consulting.

In August, Rizk was named a PharmaVoice 100 leader.

She is also a member of the Healthcare Businesswomen’s Association, Prix Galien Foundation Digital Advisory Board and Society for Clinical Research Sites (SCRS) Innovation Council.

The startup Medable has continued to grow rapidly during the pandemic, scoring another $78 million in funding to help it continue ​​advancing clients’ digital and decentralized clinical trials.

In her role at Medable, Rizk will work to bolster the company’s strategic partnerships and innovation ecosystem.

She will also endeavor to improve clinical trial diversi…

Read more
  • 0

The top digital health startups in the world

About two-fifths of the startups in CB Insights’ second annual Digital Health 150 list are engaged in telehealth, a high-demand area amid the COVID-19 pandemic.

That is one of the big takeaways from the list of 150 promising digital health startups that CB Insights released today. CB Insights’ research team picked the 150 startups after using the company’s platform to evaluate nearly 8,000 startups on factors including patent activity, business relations, investor profile, news sentiment analysis, proprietary Mosaic scores, market potential, competitive landscape, team strength and tech novelty. (Download the full report here.)

The 62 telehealth startups on the list include telemedicine platforms such as cardiology platform Heartbeat Health (New York), virtual visit platform Doctor On Demand (San Francisco), and Livi medical app creator KRY (Stockholm, Sweden). There are remote monitoring and diagnostics companies including Oura (Oulu, Finland…

Read more
  • 0